000 01295 a2200361 4500
005 20250512211105.0
264 0 _c19831123
008 198311s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(83)90158-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAltstein, M
245 0 0 _aProtection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cAug 1983
300 _a353-61 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAminopeptidases
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aBinding Sites
_xdrug effects
650 0 4 _aChelating Agents
_xpharmacology
650 0 4 _aCorpus Striatum
_xmetabolism
650 0 4 _aEnkephalin, Leucine
_xmetabolism
650 0 4 _aEnkephalins
_xmetabolism
650 0 4 _aIn Vitro Techniques
650 0 4 _aNeprilysin
650 0 4 _aProtease Inhibitors
650 0 4 _aRats
700 1 _aBachar, E
700 1 _aVogel, Z
700 1 _aBlumberg, S
773 0 _tEuropean journal of pharmacology
_gvol. 91
_gno. 4
_gp. 353-61
856 4 0 _uhttps://doi.org/10.1016/0014-2999(83)90158-9
_zAvailable from publisher's website
999 _c6352201
_d6352201